BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19644515)

  • 1. Structural bases of GM1 gangliosidosis and Morquio B disease.
    Morita M; Saito S; Ikeda K; Ohno K; Sugawara K; Suzuki T; Togawa T; Sakuraba H
    J Hum Genet; 2009 Sep; 54(9):510-5. PubMed ID: 19644515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twenty-one novel mutations in the GLB1 gene identified in a large group of GM1-gangliosidosis and Morquio B patients: possible common origin for the prevalent p.R59H mutation among gypsies.
    Santamaria R; Chabás A; Coll MJ; Miranda CS; Vilageliu L; Grinberg D
    Hum Mutat; 2006 Oct; 27(10):1060. PubMed ID: 16941474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GM1 gangliosidosis and Morquio B disease: expression analysis of missense mutations affecting the catalytic site of acid beta-galactosidase.
    Hofer D; Paul K; Fantur K; Beck M; Bürger F; Caillaud C; Fumic K; Ledvinova J; Lugowska A; Michelakakis H; Radeva B; Ramaswami U; Plecko B; Paschke E
    Hum Mutat; 2009 Aug; 30(8):1214-21. PubMed ID: 19472408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings.
    Caciotti A; Garman SC; Rivera-Colón Y; Procopio E; Catarzi S; Ferri L; Guido C; Martelli P; Parini R; Antuzzi D; Battini R; Sibilio M; Simonati A; Fontana E; Salviati A; Akinci G; Cereda C; Dionisi-Vici C; Deodato F; d'Amico A; d'Azzo A; Bertini E; Filocamo M; Scarpa M; di Rocco M; Tifft CJ; Ciani F; Gasperini S; Pasquini E; Guerrini R; Donati MA; Morrone A
    Biochim Biophys Acta; 2011 Jul; 1812(7):782-90. PubMed ID: 21497194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morquio B syndrome: a primary defect in beta-galactosidase.
    van der Horst GT; Kleijer WJ; Hoogeveen AT; Huijmans JG; Blom W; van Diggelen OP
    Am J Med Genet; 1983 Oct; 16(2):261-75. PubMed ID: 6418007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [beta-galactosidosis--GM1 gangliosidosis and Morquio B disease].
    Yoshida K; Yanagisawa N
    Nihon Rinsho; 1995 Dec; 53(12):2960-6. PubMed ID: 8577043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of beta-galactosidase mutations Asp332-->Asn and Arg148-->Ser, and a polymorphism, Ser532-->Gly, in a case of GM1 gangliosidosis.
    Zhang S; Bagshaw R; Hilson W; Oho Y; Hinek A; Clarke JT; Callahan JW
    Biochem J; 2000 Jun; 348 Pt 3(Pt 3):621-32. PubMed ID: 10839995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of beta-galactosidase and elastin binding protein in lysosomal and nonlysosomal complexes of patients with GM1-gangliosidosis.
    Caciotti A; Donati MA; Boneh A; d'Azzo A; Federico A; Parini R; Antuzzi D; Bardelli T; Nosi D; Kimonis V; Zammarchi E; Morrone A
    Hum Mutat; 2005 Mar; 25(3):285-92. PubMed ID: 15714521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotype determining alleles in GM1 gangliosidosis patients bearing novel GLB1 mutations.
    Hofer D; Paul K; Fantur K; Beck M; Roubergue A; Vellodi A; Poorthuis BJ; Michelakakis H; Plecko B; Paschke E
    Clin Genet; 2010 Sep; 78(3):236-46. PubMed ID: 20175788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired elastic-fiber assembly by fibroblasts from patients with either Morquio B disease or infantile GM1-gangliosidosis is linked to deficiency in the 67-kD spliced variant of beta-galactosidase.
    Hinek A; Zhang S; Smith AC; Callahan JW
    Am J Hum Genet; 2000 Jul; 67(1):23-36. PubMed ID: 10841810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast screening for chaperone therapy in beta-galactosidosis.
    Iwasaki H; Watanabe H; Iida M; Ogawa S; Tabe M; Higaki K; Nanba E; Suzuki Y
    Brain Dev; 2006 Sep; 28(8):482-6. PubMed ID: 16617000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular genetics of beta-galactosidase deficiency (GM1-gangliosidosis and Morquio syndrome type B)].
    Yoshida K; Yanagisawa N
    Nihon Rinsho; 1993 Sep; 51(9):2269-75. PubMed ID: 8411701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of human β-galactosidase: structural basis of Gm1 gangliosidosis and morquio B diseases.
    Ohto U; Usui K; Ochi T; Yuki K; Satow Y; Shimizu T
    J Biol Chem; 2012 Jan; 287(3):1801-12. PubMed ID: 22128166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of GM1 gangliosidosis and Morquio disease, type B. Structure-function studies of lysosomal beta-galactosidase and the non-lysosomal beta-galactosidase-like protein.
    Callahan JW
    Biochim Biophys Acta; 1999 Oct; 1455(2-3):85-103. PubMed ID: 10571006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A beta-galactosidase gene mutation identified in both Morquio B disease and infantile GM1 gangliosidosis.
    Suzuki Y; Oshima A
    Hum Genet; 1993 May; 91(4):407. PubMed ID: 8500799
    [No Abstract]   [Full Text] [Related]  

  • 16. Six novel beta-galactosidase gene mutations in Brazilian patients with GM1-gangliosidosis.
    Silva CM; Severini MH; Sopelsa A; Coelho JC; Zaha A; d'Azzo A; Giugliani R
    Hum Mutat; 1999; 13(5):401-9. PubMed ID: 10338095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of 14 novel GLB1 mutations, including five deletions, in 19 patients with GM1 gangliosidosis from South America.
    Santamaria R; Blanco M; Chabás A; Grinberg D; Vilageliu L
    Clin Genet; 2007 Mar; 71(3):273-9. PubMed ID: 17309651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical chaperone therapy: chaperone effect on mutant enzyme and cellular pathophysiology in β-galactosidase deficiency.
    Higaki K; Li L; Bahrudin U; Okuzawa S; Takamuram A; Yamamoto K; Adachi K; Paraguison RC; Takai T; Ikehata H; Tominaga L; Hisatome I; Iida M; Ogawa S; Matsuda J; Ninomiya H; Sakakibara Y; Ohno K; Suzuki Y; Nanba E
    Hum Mutat; 2011 Jul; 32(7):843-52. PubMed ID: 21520340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the canine and human acid beta-galactosidase gene.
    Ahern-Rindell AJ; Kretz KA; O'Brien JS
    Am J Med Genet; 1996 May; 63(2):340-5. PubMed ID: 8725782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (5aR)-5a-C-Pentyl-4-epi-isofagomine: A powerful inhibitor of lysosomal β-galactosidase and a remarkable chaperone for mutations associated with GM1-gangliosidosis and Morquio disease type B.
    Front S; Biela-Banaś A; Burda P; Ballhausen D; Higaki K; Caciotti A; Morrone A; Charollais-Thoenig J; Gallienne E; Demotz S; Martin OR
    Eur J Med Chem; 2017 Jan; 126():160-170. PubMed ID: 27750150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.